BioNTech plans to invest $1.33 billion in the UK for research, stock up 7%

From Yahoo Finance: 2025-05-21 15:26:00

German vaccine maker BioNTech SE plans to invest up to $1.33 billion in the UK over the next decade to expand research and development operations. The company aims to enroll 10,000 patients in clinical trials for personalized cancer treatments by 2030. The UK government will provide up to £129 million in grant funding for this initiative. BioNTech plans to establish two new R&D facilities, generating high-skilled jobs and new research hubs. BNTX stock is up over 7% in the past year.



Read more at Yahoo Finance: BioNTech Strengthens UK Ties with Investment of Up to $1.33 Billion